Tiwary C M
Clin Pediatr (Phila). 1987 Jul;26(7):349-54. doi: 10.1177/000992288702600705.
State regulations for neonatal screening for metabolic diseases do not optimally serve the needs of the dependents of the U.S. Armed Forces. Guidelines are therefore proposed for the neonatal screening for metabolic disease based both on responses received across the United States and on the unique needs of the U.S. Armed Forces. The guidelines agree with the policies outlined by various national medical and scientific organizations. It is suggested that neonates be screened for phenylketonuria (PKU), hypothyroidism, galactosemia, and maple syrup urine disease (MSUD). The screening program is cost-effective and feasible. Prior to implementing the program throughout the U.S. military, a pilot program based at the Armed Forces Institute of Pathology should be started.
美国各州关于新生儿代谢疾病筛查的规定未能充分满足美国武装部队家属的需求。因此，基于在美国各地收到的反馈以及美国武装部队的独特需求，提出了新生儿代谢疾病筛查指南。这些指南与各种国家医学和科学组织概述的政策一致。建议对新生儿进行苯丙酮尿症（PKU）、甲状腺功能减退症、半乳糖血症和枫糖尿症（MSUD）的筛查。该筛查计划具有成本效益且可行。在全美军队全面实施该计划之前，应启动一项以武装部队病理研究所为基础的试点计划。
